natgillin/translations-raw huggingface dataset:
This also includes safety data for patient visits in the post-week 144 open label extension (which patients in either treatment group who completed the 144 week blinded phase could enter).
Zajemajo tudi podatke o varnosti, pridobljene med obiski bolnikov v odprtem podaljšku raziskave po 144. tednu (v katerem so lahko sodelovali bolniki iz obeh zdravljenih skupin, ki so zaključili 144-tedensko slepo fazo raziskave).
This alternative mechanism does not work properly in cancer cells with mutations in the BRCA1 or BRCA2 genes.
Ta alternativni mehanizem v rakavih celicah z mutacijo genov BRCA1 ali BRCA2 ne deluje pravilno.
This amount is usually enough for a 4 hour session.
Ta odmerek običajno zadošča za 4-urno dializo.
This amount of alcohol may be harmful for those suffering from alcoholism as well as for pregnant or breast-feeding women, children and high-risk groups such as patients with liver disease, or epilepsy.
Ta odmerek bi utegnil škodovati alkoholikom, pa tudi nosečnicam, doječim materam, otrokom in skupinam z velikim tveganjem, na primer bolnikom z boleznijo jeter ali epilepsijo.
This analysis indicated that CXCR4-virus emerged from a pre-existing CXCR4-using reservoir not detected at baseline, rather than from mutation of CCR5-tropic virus present at baseline.
Analiza je pokazala, da je virus CXCR4 vzniknil iz predobstoječega, izhodiščno neodkritega rezervoarja uporabnikov CXCR4 in ni nastal zaradi mutacije izhodiščno prisotnega CCR5-tropnega virusa.
This analysis was based on data collected from adults with GIST or solid tumours, and from paediatric patients with solid tumours.
Ta analiza je temeljila na podatkih, pridobljenih pri odraslih z GIST ali čvrstimi tumorji ter pri pediatričnih bolnikih s čvrstimi tumorji.
this anti-HIV medicine belongs to the same class as PREZISTA
zdravljenje okužbe s HIV, zdravilo je uvrščeno v isto skupino kot zdravilo PREZISTA
This antibody testing should be provided upon request of a physician and when the MAH receives a report suggestive of a possible immune reaction or lack of efficacy.
To testiranje na protitelesa je treba omogočiti na zahtevo zdravnika in kadar imetnik dovoljenja za promet z zdravilom dobi poročilo, značilno za morebitne imunske reakcije ali neučinkovitost zdravila.
This applies especially to the medicines listed below taken at the same time with Kinzalkomb:
To velja zlasti za spodaj našteta zdravila, ki jih jemljete hkrati z zdravilom Kinzalkomb:
This applies especially to the medicines listed below taken at the same time with MicardisPlus:
To velja zlasti za spodaj našteta zdravila, ki jih jemljete hkrati z zdravilom MicardisPlus:
This applies especially to the medicines listed below taken at the same time with Tolucombi:
To velja zlasti za spodaj našteta zdravila, ki jih jemljete hkrati z zdravilom Tolucombi:
This applies especially to the medicines listed below taken at the same time with Tolura:
To velja zlasti za našteta zdravila, kadar jih jemljete sočasno z zdravilom Tolura:
This applies especially to the medicines listed below taken at the same time with Twynsta:
To velja zlasti za spodaj našteta zdravila, kadar jih jemljete hkrati z zdravilom Twynsta:
This applies to all products including heparin and acetylsalicylic acid, which should be administered before and following the administration of reteplase to reduce the risk of re-thrombosis
To se nanaša na vsa zdravila, vključno s heparinom in acetilsalicilno kislino, ki se jih za zmanjšanje tveganja ponovne tromboze daje pred dajanjem reteplaze in po njem.
This applies to all products including heparin and acetylsalicylic acid, which should be administered before and following the administration of reteplase to reduce the risk of re-thrombosis.
To se nanaša na vsa zdravila, vključno s heparinom in acetilsalicilno kislino, ki se jih za zmanjšanje tveganja ponovne tromboze daje pred dajanjem reteplaze in po njem.
This applies to both Crohn’s disease patients and rheumatoid arthritis patients.
To velja tako za bolnike s Crohnovo boleznijo kot za tiste z revmatoidnim artritisom.
This assessment should optimise the patient’s status, with particular attention to blood pressure and fluid management.
Ocena mora optimizirati bolnikovo stanje, posebno pozornost pa je treba nameniti krvnemu tlaku in uravnavanju tekočin.
This assumption is supported by the results of an ex-vivo study which compared pig and rabbit liver metabolic profiles.
To predpostavko podpirajo rezultati ex- vivo študije, ki je primerjala metabolne profile v prašičjih in kunčjih jetrih.
This authorisation was based on the authorisation granted to Avamys in January 2008 (‘informed consent’).
Ta odobritev je temeljila na odobritvi dovoljenja za promet z zdravilom Avamys januarja 2008 (z „obveščenim soglasjem“).
This authorisation was based on the authorisation granted to Cialis in 2002 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet z zdravilom Cialis, ki je bilo izdano leta 2002 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Competat on 28 July 2006 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet z zdravilom Competat, ki je bilo izdano 28. julija 2006 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Daxas in 2010 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet z zdravilom Daxas, ki je bilo izdano leta 2010 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Exelon in 1998 (‘informed consent’).
Ta odobritev je temeljila na dovoljenju za promet, odobrenem za zdravilo Exelon leta 1998 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Fosavance in 2005 (‘informed consent’).
Ta odobritev je temeljila na dovoljenju za promet z zdravilom Fosavance, izdanemu leta 2005 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Fosavance in 2005 (‘informed consent’).
To dovoljenje temelji na dovoljenju, ki je bilo leta 2005 odobreno za zdravilo Fosavance (s „privolitvijo po soglasju“).
This authorisation was based on the authorisation granted to Iscover in 1998 (‘informed consent’).
Podlaga za odobritev dovoljenja je bila odobritev za zdravilo Iscover iz leta 1998 („privolitev po pojasnilu“).
This authorisation was based on the authorisation granted to Janumet in 2008 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet za zdravilo Janumet, ki je bilo izdano leta 2008 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Januvia in 2007 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet za zdravilo Januvia, ki je bilo izdano leta 2007 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Januvia in 2007 (‘informed consent’).
Ta odobritev je temeljila na dovoljenju za promet, odobrenemu zdravilu Januvia leta 2007 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Plavix in 1998 (‘informed consent’).
Podlaga za odobritev dovoljenja je bila odobritev za zdravilo Plavix iz leta 1998 („privolitev po pojasnilu“).
This authorisation was based on the authorisation granted to Prepandrix in 2008 (‘informed consent’).
To dovoljenje je temeljilo na dovoljenju, ki je bilo leta 2008 odobreno za zdravilo Prepandrix („z obveščenim soglasjem“).
This authorisation was based on the authorisation granted to Stalevo in 2003 (‘informed consent’).
Ta odobritev je temeljila na dovoljenju za promet, odobrenem za zdravilo Stalevo leta 2003 (uporaba dokumentacije s soglasjem).
This authorisation was based on the authorisation granted to Taxotere in 1995 (‘informed consent’).
Podlaga za odobritev dovoljenja je bila odobritev za zdravilo Taxotere iz leta 1995 („privolitev po pojasnilu“).
This authorisation was based on the authorisation granted to Xeplion in 2011 (‘informed consent’).
Izdaja tega dovoljenja je temeljila na dovoljenju za promet z zdravilom Xeplion, ki je bilo izdano leta 2011 („uporaba dokumentacije s soglasjem“).
This authorisation was based on the authorisation of Rasilez HCT in 2009 (‘informed consent’).
Odobritev je temeljila na dovoljenju za promet z zdravilom Rasilez HCT iz leta 2009 („privolitev po pojasnilu“).
This bacterium causes infections in birds, generally in the lungs and the ‘air sacs’, the specialised bags within the bird’s body where air is stored during breathing.
Ta bakterija povzroča okužbe pri ptičih, predvsem v pljučih in „zračnih mešičkih“, tj. posebnih vrečkah v telesu ptičev, v katerih se shranjuje zrak med dihanjem.
This bacterium may be the reason for your stomach (gastric) condition.
Ta bakterija je lahko vzrok za vaše želodčne težave.
This bar code is the doctor's reference number used at the analysing laboratory as a patient identifier; the two spare bar code labels are for the doctor's use on the patient notes/files etc.
Preostali dve etiketi s črtnimi kodami sta namenjeni zdravnikovi uporabi za kartoteko bolnika itd.
This becomes more likely if the medicine that is used for final follicular maturation (containing human chorionic gonadotrophin , hCG) is administered (see in section 3. under “How much to use” for details).
To je bolj verjetno, če se daje zdravilo, ki se uporablja za spodbuditev končnega folikularnega zorenja (ki vsebuje humani horionski gonadotropin – hCG) (za več podrobnosti glejte poglavje 3 „Koliko zdravila uporabiti“).
This being a conditional marketing authorisation and pursuant to Article 14(7) of regulation (EC) No.
Ker gre za pogojno dovoljenje za promet z zdravilom in ob upoštevanju člena 14(7) Uredbe (ES) št.
This being a marketing authorisation under exceptional circumstances and pursuant to Article 14(7) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures:
726/2004, mora imetnik dovoljenja za promet z zdravilom v določenem časovnem okviru izvesti naslednje ukrepe:
This being a marketing authorisation under exceptional circumstances and pursuant to Article 14(8) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures:
726/2004, mora imetnik dovoljenja za promet v določenem časovnem okviru izvesti naslednje ukrepe:
This being an approval under exceptional circumstances and pursuant to Article 14(8) of Regulation (EC) No 726/2004, the MAH shall complete, within the stated timeframe, the following measures.
726/2004, mora imetnik dovoljenja za promet v določenem časovnem okvirju izvesti naslednje ukrepe.
This being an approval under exceptional circumstances and pursuant to Article 14(8) of Regulation (EC) No 726/2004, the MAH shall conduct, within the stated timeframe, the following measures:
726/2004, mora imetnik dovoljenja za promet v določenem časovnem okvirju izvesti naslednje ukrepe:
This being an approval under exceptional circumstances and pursuant to Article 14(8) of Regulation (EC) No 726/2004, the MAH shall conduct, within the stated timeframe, the following measures:
Ker gre za odobritev v izjemnih okoliščinah in ob upoštevanju člena 14(8) Uredbe (EC) št.726/2004, mora imetnik dovoljenja za promet v določenem časovnem okvirju izvesti naslednje ukrepe:
This belongs to a group of medicines called anti- fungals.
Spada v skupino zdravil, imenovanih antimikotiki.
This belongs to a group of medicines called anti-platelet medicines.
To zdravilo spada v skupino zdravil, imenovanih antiagregacijska zdravila.
This belongs to a group of medicines called ‘anti-retrovirals’.
Spada v skupino zdravil imenovanih »protiretrovirusna« zdravila.
This belongs to a group of medicines called ‘coronary vasodilators’.
Slednja sodi v skupino zdravil, imenovanih "koronarni vazodilatatorji".
This belongs to a group of medicines called “immuno-suppressants”.
Spada v skupino zdravil za zaviranje imunske odzivnosti.
This belongs to a group of medicines called “immunosuppressants”.
Spada v skupino zdravil za zaviranje imunske odzivnosti.
This beneficial effect of the lower dose was also supported by improvements in other measures of effectiveness, including those directly linked to patients’ daily activities.
Ta koristen učinek manjšega odmerka so potrdila tudi izboljšanja po drugih merilih za oceno učinkovitosti, vključno s tistimi, ki so bila neposredno povezana z vsakodnevnimi dejavnostmi bolnikov.
This benefit was consistent across all prespecified subgroups including patients’ age and gender, infarct location, and type of fibrinolytic or heparin used.
Ta koristni učinek je bil prisoten v vseh prehodno opredeljenih podskupinah glede na bolnikovo starost ali spol, mesto infarkta in tip uporabljenega fibrinolitika ali heparina.
This benefit was consistent across all prespecified subgroups including patients’ age and gender, infarct location, and type of fibrinolytic or heparin used.
Ta koristni učinek se je pojavljal v vseh podskupinah, ki so bile predhodno opredeljene glede na bolnikovo starost ali spol, mesto infarkta in tip uporabljenega fibrinolitika ali heparina.
This benefit was consistent across all prespecified subgroups including patients’ age and gender, infarct location, and type of fibrinolytic or heparin used.
Ta koristni učinek se je pojavljal v vseh prehodno opredeljenih podskupinah glede na bolnikovo starost ali spol, mesto infarkta in tip uporabljenega fibrinolitika ali heparina.
This benefit was consistent across all prespecified subgroups including patients’ age and gender, infarct location, and type of fibrinolytic or heparin used.
Ta koristni učinek se je pojavljal v vseh prehodno opredeljenih podskupinah glede na bolnikovo starost ali spol, mesto infarkta in vrsto uporabljenega fibrinolitika ali heparina.
This binding results in activation of some oestrogenic pathways (agonism) and blockade of other oestrogenic pathways (antagonism).
Z vezavo se aktivirajo nekatere estrogenske poti (agonizem) in blokirajo druge estrogenske poti (antagonizem).
This booklet was last revised in {MM/YYYY}.
Navodilo je bilo nazadnje revidirano 11/2013.
This boosts elvitegravir’s antiviral effect.
To okrepi protivirusni učinek elvitegravirja.
This box containing 7 pre-filled syringes is part of a 28-multipack.
Ta škatla s 7 napolnjenimi injekcijskimi brizgami je del pakiranja po 28.
This breath should be held in for as long as possible (at least 3-4 seconds).
Zadržite ta dih, kolikor je mogoče dolgo (vsaj 3 do 4 sekunde).
This brings the contents to room temperature.
Tako se bo vsebina ogrela na sobno temperaturo.
This can be accomplished by withdrawing a volume of the sodium chloride 9 mg/mL (0.9%) solution for infusion from the 250-mL glass bottle or infusion bag equal to the volume of reconstituted Inflectra.
To naredite tako, da iz 250 ml steklenice ali infuzijske vrečke odvzamete tisti volumen 9 mg/ml (0,9 %) raztopine natrijevega klorida za infundiranje, ki ustreza volumnu rekonstituiranega zdravila Inflectra.
This can be accomplished by withdrawing a volume of the sodium chloride 9 mg/mL (0.9%) solution for infusion from the 250-mL glass bottle or infusion bag equal to the volume of reconstituted Remsima.
To naredite tako, da iz 250 ml steklenice ali infuzijske vrečke odvzamete tisti volumen 9 mg/ml (0,9 %) raztopine natrijevega klorida za infundiranje, ki ustreza volumnu rekonstituiranega zdravila Remsima.
This can be attached to the patient’s notes so that hospital staff are made aware of these effects of the medicine.
Ta nalepka se lahko nalepi v bolnikovo kartoteko, da je zdravstveno osebje obveščeno o teh učinkih zdravila.
This can be caused
Do tega lahko pride, če:
This can be caused if: you take too much Humalog BASAL or other insulin;
Do tega lahko pride, če: vzamete preveč zdravila Humalog BASAL ali insulina kake druge vrste;
This can be caused if: you take too much Humalog Mix25 or other insulin;
Do tega lahko pride, če: vzamete preveč zdravila Humalog Mix25 ali insulina kake druge vrste;
This can be caused if: you take too much Humalog Mix50 or other insulin;
Do tega lahko pride, če: vzamete preveč zdravila Humalog Mix50 ali insulina kake druge vrste;
This can be caused if: you take too much Humalog or other insulin;
Do tega lahko pride, če: vzamete preveč zdravila Humalog ali insulina kake druge vrste;
This can be discussed with your doctor.
Pogovorite se o tem s svojim zdravnikom.
This can be discussed with your doctor.
Pogovorite se s svojim zdravnikom o tem.
This can be discussed with your doctor. if you are a man who is taking ribavirin, do not have sex with a pregnant woman unless you use a condom.
O tem se lahko pogovorite s svojim zdravnikom. če ste moški in jemljete ribavirin, ne smete imeti spolnih odnosov z nosečo žensko brez uporabe kondoma.
This can be discussed with your doctor. if you are a man who is taking ribavirin, do not have sex with a pregnant woman unless you use a condom.
O tem se lahko pogovorite z zdravnikom. če ste moški in jemljete ribavirin, ne smete imeti spolnih odnosov z nosečo žensko brez uporabe kondoma.
This can be done either by leaving the vials at room temperature for about an hour or by holding them in your hands for a few minutes.
To se doseže tako, da viali približno eno uro pustite pri sobni temperaturi ali da ju nekaj minut držite v rokah.
This can be fatal in some people. lactic acidosis (see the next section, ‘Other possible side effects of therapy for Hepatitis B’)
Pri nekaterih bolnikih je to lahko smrtno. laktacidoza (glejte naslednje poglavje, "Drugi možni neželeni učinki zdravljenja hepatitisa B").
This can be given as 150 mg (half of a tablet) taken in the morning and 300 mg (one whole tablet) taken in the evening, or 450 mg (one and a half tablets) once a day as advised by your doctor.
Odmerek se lahko daje v obliki 150 mg odmerka (polovica tablete) zjutraj in v obliki 300 mg odmerka (ena cela tableta) zvečer ali po posvetu z zdravnikom v obliki 450 mg odmerka (ena tableta in pol) enkrat na dan.
This can be given as 150 mg (half of a tablet) twice daily, or 300 mg (one whole tablet) once a day as advised by your doctor.
Odmerek se lahko daje v obliki 150 mg odmerka (polovica tablete) dvakrat na dan ali po posvetu z zdravnikom v obliki 300 mg odmerka (ena cela tableta) enkrat na dan.
This can be given as 75 mg (half a 150 mg tablet) twice a day (leaving approximately 12 hours between each dose), or 150 mg (one 150 mg tablet) once a day as advised by your doctor.
Odmerek se lahko daje v obliki 75 mg odmerka (polovica 150 mg tablete) dvakrat na dan (z razmikom približno 12 ur med obema odmerkoma) ali po posvetu z zdravnikom v obliki 150 mg odmerka (ena cela 150 mg tableta) enkrat na dan.
This can be harmful for those suffering from alcoholism, and is also to be taken into account in pregnant or breast-feeding women and high-risk groups such as patients with liver disease, or epilepsy.
Ta količina lahko škoduje tistim, ki imajo težave z alkoholizmom, upoštevati pa jo je treba tudi pri nosečih ali doječih ženskah in skupinah z velikim tveganjem, kot so bolniki z obolenjem jeter ali epilepsijo.
This can be infused over 60 or 90 minutes as detailed in 4.2.
Odmerek lahko infundirate v 60 ali 90 minutah, kakor je podrobno opisano v poglavju 4.2.
This can be seen in a blood test.
To lahko pokaže krvni test.
This can be seen using a special imaging technique called single-photon-emission computed tomography (SPECT), which detects the radioactive iodine-123.
To lahko opazujemo s posebno tehniko slikanja, imenovano enofotonska izsevna tomografija ali SPECT (single photon emission computed tomography), ki zazna radioaktivni jod–123.
This can be serious if your blood glucose level becomes very high.
Če je koncentacija krvega sladkorja prevelika je to zelo nevarno.
This can be serious if your blood glucose level becomes very high.
Če je koncentacija krvnega sladkorja prevelika je to zelo nevarno.
This can be serious if your blood glucose level becomes very high.
Če je koncentacija krvnega sladkorja prevelika, je to zelo nevarno.
This can be serious.
Ta je lahko resna.
This can be taken as either one 150 mg tablet twice a day (leaving approximately 12 hours between each dose), or two 150 mg tablets once a day as advised by your doctor.
Odmerek se lahko jemlje v obliki ene 150 mg tablete dvakrat na dan (z razmikom približno 12 ur med obema odmerkoma) ali po posvetu z zdravnikom v obliki dveh 150 mg tablet enkrat na dan.
This can be taken either as 15 ml (150 mg) twice a day (leaving approximately 12 hours between each dose), or as 30 ml (300 mg) once a day.
Odmerek se lahko jemlje kot 15 ml (150 mg) dvakrat na dan (z razmikom približno 12 ur med obema odmerkoma) ali kot 30 ml (300 mg) enkrat na dan.
This can be taken either as 300 mg (15 ml) twice a day or 600 mg (30 ml) once a day.
Vzamete ga lahko 300 mg (15 ml) dvakrat na dan ali 600 mg (30 ml) enkrat na dan.
This can be taken either as one 300 mg tablet twice a day or two 300 mg tablets once a day.
Vzamete ga lahko kot eno 300 mg tableto dvakrat na dan ali kot dve 300 mg tableti enkrat na dan.
This can cause dryness leading to painful sexual intercourse, and irritation and soreness around the genital area.
Zaradi tega se lahko pojavi suhost, ki ima za posledico boleče spolne odnose ter draženje in bolečine v predelu genitalij.
This can cause muscle problems, fever and mental changes.
To lahko povzroči težave z mišicami, povišano telesno temperaturo ali spremembe duševnega stanja.
This can even be life threatening.
Ta je lahko tudi smrtna.
This can even be life threatening.
To je lahko celo smrtno nevarno.
This can give the doctor valuable information such as the location of a tumour.
To daje lahko zdravniku dragocene podatke kot je mesto tumorja.
This can happen especially when you start using Leganto or when your dose is increased.
To se lahko zgodi na začetku zdravljenja z zdravilom Leganto ali ob povečanju odmerka.
This can happen especially when you start using Neupro or when your dose is increased.
To se lahko zgodi na začetku zdravljenja z zdravilom Neupro ali ob povečanju odmerka.
This can happen if there is slightly too much pressure in the vial.
Do tega lahko pride, če je pritisk v viali nekoliko previsok.
This can happen if you are sick with a fever, vomiting, or diarrhoea
To se lahko zgodi, če vam je slabo in imate vročino, bruhate ali imate drisko.
This can happen straight away or later on in your treatment.
To se lahko zgodi takoj ali pozneje med zdravljenjem.
This can help to lower some of the side effects (febrile reactions) of Synflorix.
To lahko pomaga zmanjšati nekatere neželene učinke cepiva Synflorix (vročinske reakcije).
This can help to reduce the number of relapses that you have and slow down the disabling effects of MS.
To lahko pomaga pri zmanjšanju števila recidivov, ki jih imate, in upočasni onesposabljajoče učinke MS.
This can help to reduce the number of relapses that you have and slow down the disabling effects of MS.
To lahko pomaga pri zmanjšanju števila recidivov, ki jih imate, in upočasnitvi onesposabljajočih učinkov MS.
This can include medical history, possible previous contact with tuberculosis, and/or appropriatescreening such as lung x-ray, tuberculin test and/or interferon-gammarelease assay, as applicable.
To lahko obsega zdravstveno anamnezo, ugotavljanje možnih predhodnih stikov s tuberkulozo in/ali ustrezne presejalne postopke, npr. rentgensko slikanje pljuč, tuberkulinski test in/ali preskus sproščanja interferona gama, če pride v poštev.
This can increase the length of time the patient stays in remission.
To lahko posledično podaljša obdobje bolnikove remisije.
This can increase vitamin E levels in the blood and help to prevent neurological deterioration (problems in the nervous system) due to vitamin E deficiency.
Pri tem se povečajo ravni vitamina E v krvi in preprečijo nevrološke okvare (težave z živčnim sistemom), nastale zaradi pomanjkanja vitamina E.
This can increase your risk of side effects with Aerivio Spiromax, including irregular heartbeats, or may make side effects worse.
To lahko poveča tveganje za neželene učinke z zdravilom Aerivio Spiromax, vključno z nerednim srčnim utripom, ali nekatere neželene učinke poslabša.